514 related articles for article (PubMed ID: 18035865)
21. Insight into antidiabetic therapies: a report from the 43rd annual meeting of the European Association for the Study of Diabetes.
Rabasseda X
Timely Top Med Cardiovasc Dis; 2007 Oct; 11():E28. PubMed ID: 18297140
[No Abstract] [Full Text] [Related]
22. Impact of glucose-lowering drugs on cardiovascular disease in type 2 diabetes.
Ferrannini E; DeFronzo RA
Eur Heart J; 2015 Sep; 36(34):2288-96. PubMed ID: 26063450
[TBL] [Abstract][Full Text] [Related]
23. Are you up-to-date on diabetes medications?
Scemons D
Nursing; 2007 Jul; 37(7):45-9; quiz 49-50. PubMed ID: 17603373
[TBL] [Abstract][Full Text] [Related]
24. What to add in with metformin in type 2 diabetes?
Petrie JR; Adler A; Vella S
QJM; 2011 Mar; 104(3):185-92. PubMed ID: 21156663
[TBL] [Abstract][Full Text] [Related]
25. Alternative Agents in Type 1 Diabetes in Addition to Insulin Therapy: Metformin, Alpha-Glucosidase Inhibitors, Pioglitazone, GLP-1 Agonists, DPP-IV Inhibitors, and SGLT-2 Inhibitors.
DeGeeter M; Williamson B
J Pharm Pract; 2016 Apr; 29(2):144-59. PubMed ID: 25312263
[TBL] [Abstract][Full Text] [Related]
26. Network meta-analysis of treatments for type 2 diabetes mellitus following failure with metformin plus sulfonylurea.
Lozano-Ortega G; Goring S; Bennett HA; Bergenheim K; Sternhufvud C; Mukherjee J
Curr Med Res Opin; 2016 May; 32(5):807-16. PubMed ID: 26700585
[TBL] [Abstract][Full Text] [Related]
27. [Management of type 2 diabetes: new or previous agents, how to choose?].
Halimi S
Presse Med; 2013 May; 42(5):861-70. PubMed ID: 23643613
[TBL] [Abstract][Full Text] [Related]
28. Complications of diabetes therapy.
Corathers SD; Peavie S; Salehi M
Endocrinol Metab Clin North Am; 2013 Dec; 42(4):947-70. PubMed ID: 24286957
[TBL] [Abstract][Full Text] [Related]
29. Important differences in the durability of glycaemic response among second-line treatment options when added to metformin in type 2 diabetes: a retrospective cohort study.
Mamza J; Mehta R; Donnelly R; Idris I
Ann Med; 2016; 48(4):224-34. PubMed ID: 26982210
[TBL] [Abstract][Full Text] [Related]
30. Non-insulin pharmacological therapies for treating type 1 diabetes.
Frandsen CS; Dejgaard TF; Madsbad S; Holst JJ
Expert Opin Pharmacother; 2018 Jun; 19(9):947-960. PubMed ID: 29991320
[TBL] [Abstract][Full Text] [Related]
31. Predictors of response to dipeptidyl peptidase-4 inhibitors: evidence from randomized clinical trials.
Monami M; Cremasco F; Lamanna C; Marchionni N; Mannucci E
Diabetes Metab Res Rev; 2011 May; 27(4):362-72. PubMed ID: 21309062
[TBL] [Abstract][Full Text] [Related]
32. New approaches to treating type 2 diabetes mellitus in the elderly: role of incretin therapies.
Abbatecola AM; Maggi S; Paolisso G
Drugs Aging; 2008; 25(11):913-25. PubMed ID: 18947259
[TBL] [Abstract][Full Text] [Related]
33. Novel pharmacologic agents for type 2 diabetes.
Uwaifo GI; Ratner RE
Endocrinol Metab Clin North Am; 2005 Mar; 34(1):155-97. PubMed ID: 15752927
[TBL] [Abstract][Full Text] [Related]
34. Pharmacologic Therapy of Type 2 Diabetes.
Wright JJ; Tylee TS
Med Clin North Am; 2016 Jul; 100(4):647-63. PubMed ID: 27235609
[TBL] [Abstract][Full Text] [Related]
35. Type 2 diabetes: the many facets of care.
Hall MA
Home Healthc Nurse; 2008 Jun; 26(6):346-53; quiz 354-5. PubMed ID: 18562819
[TBL] [Abstract][Full Text] [Related]
36. Oral hypoglycaemics - a review of the evidence.
Phillips PJ; Twigg SM
Aust Fam Physician; 2010 Sep; 39(9):651-3. PubMed ID: 20877770
[TBL] [Abstract][Full Text] [Related]
37. Diabetes, antidiabetic medications and risk of dementia: A systematic umbrella review and meta-analysis.
Kuate Defo A; Bakula V; Pisaturo A; Labos C; Wing SS; Daskalopoulou SS
Diabetes Obes Metab; 2024 Feb; 26(2):441-462. PubMed ID: 37869901
[TBL] [Abstract][Full Text] [Related]
38. Non-insulin treatments for Type 1 diabetes: critical appraisal of the available evidence and insight into future directions.
Wright LA; Hirsch IB
Diabet Med; 2019 Jun; 36(6):665-678. PubMed ID: 30801765
[TBL] [Abstract][Full Text] [Related]
39. Frailty and safety: the example of diabetes.
Abbatecola AM; Olivieri F; Corsonello A; Strollo F; Fumagalli A; Lattanzio F
Drug Saf; 2012 Jan; 35 Suppl 1():63-71. PubMed ID: 23446787
[TBL] [Abstract][Full Text] [Related]
40. Which oral agent to use when metformin is no longer effective?
Bannon M
QJM; 2011 Mar; 104(3):183-4. PubMed ID: 21330402
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
